Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anne Fuhlbrigge

Concepts (429)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
98
2025
2282
9.160
 Why?
Adrenal Cortex Hormones
28
2025
556
3.340
 Why?
Anti-Asthmatic Agents
28
2025
393
3.170
 Why?
Forced Expiratory Volume
19
2019
531
1.580
 Why?
Pulmonary Disease, Chronic Obstructive
11
2022
1036
1.390
 Why?
Severity of Illness Index
20
2020
2822
1.000
 Why?
Administration, Inhalation
25
2025
683
0.970
 Why?
Anti-Inflammatory Agents
10
2016
496
0.890
 Why?
Albuterol
5
2015
110
0.850
 Why?
Lung Transplantation
10
2017
313
0.850
 Why?
Bronchodilator Agents
12
2016
247
0.830
 Why?
Budesonide
14
2016
89
0.810
 Why?
Remote Consultation
4
2025
50
0.790
 Why?
Nedocromil
11
2016
32
0.740
 Why?
Humans
129
2025
136803
0.730
 Why?
Nasal Polyps
1
2021
59
0.710
 Why?
Self Report
3
2023
822
0.710
 Why?
Endpoint Determination
2
2020
77
0.690
 Why?
Pharmacogenetics
2
2015
179
0.680
 Why?
Food Hypersensitivity
1
2022
183
0.630
 Why?
Sinusitis
1
2021
221
0.610
 Why?
Virus Diseases
1
2021
213
0.600
 Why?
Lung
7
2019
4063
0.600
 Why?
Physicians
2
2021
907
0.580
 Why?
Glucocorticoids
4
2022
593
0.580
 Why?
Hospitalization
13
2020
2184
0.570
 Why?
Symptom Assessment
1
2019
128
0.570
 Why?
Sleep Apnea, Obstructive
1
2021
291
0.540
 Why?
Oxygen Inhalation Therapy
4
2020
157
0.520
 Why?
Androstadienes
3
2012
107
0.520
 Why?
Child
53
2022
21819
0.520
 Why?
Bone Density
2
2014
487
0.510
 Why?
Disease Progression
14
2020
2751
0.510
 Why?
Managed Care Programs
8
2008
130
0.500
 Why?
Male
82
2025
67330
0.500
 Why?
Emergency Service, Hospital
9
2013
2048
0.500
 Why?
Adult
47
2025
37643
0.490
 Why?
Precision Medicine
1
2020
426
0.490
 Why?
Female
81
2025
72816
0.470
 Why?
Cost Savings
1
2015
84
0.460
 Why?
Patient Reported Outcome Measures
1
2018
402
0.460
 Why?
Adrenergic beta-2 Receptor Agonists
4
2020
37
0.450
 Why?
Practice Patterns, Physicians'
7
2020
1301
0.450
 Why?
Middle Aged
40
2025
33239
0.420
 Why?
Peak Expiratory Flow Rate
2
2011
37
0.420
 Why?
Cost-Benefit Analysis
7
2022
587
0.420
 Why?
Phenotype
6
2025
3189
0.400
 Why?
Comorbidity
4
2021
1614
0.370
 Why?
Academic Medical Centers
3
2024
504
0.360
 Why?
Surveys and Questionnaires
14
2022
5744
0.350
 Why?
Adolescent
37
2019
21385
0.350
 Why?
Administration, Oral
6
2021
813
0.340
 Why?
Quality of Life
12
2023
2878
0.340
 Why?
Medical Records Systems, Computerized
3
2008
92
0.340
 Why?
Mentors
1
2012
200
0.340
 Why?
United States
23
2022
14691
0.330
 Why?
Respiratory Function Tests
10
2015
595
0.330
 Why?
Child, Preschool
31
2016
10997
0.320
 Why?
Treatment Outcome
16
2025
10748
0.320
 Why?
Faculty, Medical
1
2012
283
0.320
 Why?
Interprofessional Relations
3
2021
281
0.320
 Why?
Child Development
1
2014
464
0.310
 Why?
Spirometry
8
2020
281
0.310
 Why?
Oxygen
3
2018
930
0.300
 Why?
Group Practice
1
2008
7
0.300
 Why?
Anti-Allergic Agents
2
2008
46
0.290
 Why?
Aged
22
2022
23808
0.290
 Why?
Computer Simulation
1
2012
973
0.290
 Why?
Dyspnea
3
2022
254
0.270
 Why?
Drug Utilization
4
2005
169
0.260
 Why?
Primary Health Care
5
2025
1722
0.250
 Why?
Primary Graft Dysfunction
2
2017
30
0.250
 Why?
Follow-Up Studies
17
2017
5106
0.250
 Why?
Quality Assurance, Health Care
1
2008
322
0.250
 Why?
Bronchiolitis Obliterans
3
2017
69
0.240
 Why?
Gift Giving
1
2005
11
0.240
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.240
 Why?
Allergists
2
2022
12
0.240
 Why?
Respiratory Sounds
1
2006
125
0.240
 Why?
Randomized Controlled Trials as Topic
7
2020
1462
0.230
 Why?
Genetic Testing
1
2008
453
0.230
 Why?
Delivery of Health Care
2
2021
935
0.230
 Why?
Retrospective Studies
18
2024
15510
0.220
 Why?
Medication Adherence
2
2023
468
0.220
 Why?
Cohort Studies
14
2013
5704
0.220
 Why?
Specialization
2
2025
143
0.220
 Why?
Time Factors
10
2020
6809
0.210
 Why?
Natural Language Processing
1
2025
94
0.210
 Why?
Leadership
2
2022
382
0.210
 Why?
Antibodies, Monoclonal
2
2008
1430
0.210
 Why?
Massachusetts
5
2016
172
0.210
 Why?
Medicine
1
2025
121
0.210
 Why?
Rhinitis, Allergic, Perennial
1
2003
23
0.200
 Why?
Genetic Variation
1
2008
985
0.200
 Why?
Recurrence
5
2013
1055
0.200
 Why?
Health Status
1
2008
788
0.200
 Why?
Steroids
8
2011
167
0.200
 Why?
Genetic Predisposition to Disease
2
2025
2412
0.200
 Why?
Predictive Value of Tests
9
2012
2022
0.190
 Why?
Multicenter Studies as Topic
4
2018
308
0.190
 Why?
Young Adult
11
2019
13129
0.190
 Why?
Beclomethasone
1
2022
27
0.190
 Why?
Prevalence
4
2022
2710
0.190
 Why?
Models, Theoretical
4
2007
575
0.180
 Why?
Desensitization, Immunologic
1
2022
95
0.180
 Why?
Tiotropium Bromide
2
2018
19
0.180
 Why?
Nebulizers and Vaporizers
2
2020
86
0.180
 Why?
Biomarkers
3
2021
4145
0.180
 Why?
Patient Preference
1
2023
190
0.180
 Why?
Social Class
2
2022
281
0.170
 Why?
Churg-Strauss Syndrome
1
2020
26
0.170
 Why?
Pulmonologists
1
2020
14
0.170
 Why?
Bronchoconstriction
3
2011
32
0.170
 Why?
Granulomatosis with Polyangiitis
1
2020
44
0.170
 Why?
Capacity Building
1
2021
63
0.170
 Why?
Electronic Health Records
2
2025
1046
0.170
 Why?
Muscarinic Antagonists
1
2020
29
0.170
 Why?
Agammaglobulinemia
1
2020
34
0.170
 Why?
Physician-Patient Relations
2
2021
548
0.160
 Why?
Risk Factors
12
2018
10332
0.160
 Why?
Practice Guidelines as Topic
5
2020
1572
0.160
 Why?
Air Pollution, Indoor
2
2002
179
0.160
 Why?
Treatment Adherence and Compliance
1
2019
26
0.150
 Why?
Exercise Test
1
2022
625
0.150
 Why?
Receptors, IgE
2
2009
45
0.150
 Why?
Prognosis
8
2017
4013
0.140
 Why?
Allergens
1
2021
408
0.140
 Why?
Fossil Fuels
1
1997
10
0.140
 Why?
Vitamin D
2
2012
397
0.140
 Why?
Emergency Medical Services
2
2007
547
0.140
 Why?
Alemtuzumab
1
2017
15
0.140
 Why?
Drug Prescriptions
2
2011
244
0.140
 Why?
Hypersensitivity
1
2020
257
0.140
 Why?
Photopheresis
1
2017
9
0.140
 Why?
Biological Products
1
2020
215
0.130
 Why?
Respiration
1
2017
199
0.130
 Why?
Respiration Disorders
1
1997
77
0.130
 Why?
Physicians, Primary Care
3
2021
236
0.130
 Why?
Drug Combinations
3
2012
343
0.130
 Why?
Aged, 80 and over
6
2019
7593
0.130
 Why?
Statistics, Nonparametric
1
2017
431
0.130
 Why?
Immunomodulation
1
2017
98
0.130
 Why?
Drug Therapy, Combination
5
2020
1062
0.130
 Why?
Patient Admission
1
2018
190
0.120
 Why?
Socioeconomic Factors
4
2022
1282
0.120
 Why?
Breath Tests
2
2008
87
0.120
 Why?
Scopolamine Derivatives
1
2015
7
0.120
 Why?
Embolism, Fat
1
2015
11
0.120
 Why?
Immunoglobulin G
1
2020
887
0.120
 Why?
Tobacco Smoke Pollution
2
2010
261
0.120
 Why?
Transplants
1
2015
36
0.120
 Why?
Cholinergic Antagonists
1
2015
30
0.120
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2015
104
0.120
 Why?
Fluticasone-Salmeterol Drug Combination
2
2012
12
0.120
 Why?
Carcinoma, Bronchogenic
1
2015
20
0.120
 Why?
Referral and Consultation
1
2021
780
0.120
 Why?
Genomics
2
2018
790
0.120
 Why?
Longitudinal Studies
6
2017
2829
0.110
 Why?
Postoperative Complications
2
2017
2639
0.110
 Why?
Overweight
2
2011
557
0.110
 Why?
Respiratory Tract Infections
2
2012
394
0.110
 Why?
Telemedicine
1
2023
852
0.110
 Why?
Ambulatory Care Information Systems
2
2005
5
0.110
 Why?
Prednisolone
1
2014
82
0.110
 Why?
Graft Rejection
2
2013
620
0.110
 Why?
Guideline Adherence
3
2020
546
0.110
 Why?
Risk
4
2015
908
0.110
 Why?
Education, Medical, Continuing
2
2005
127
0.110
 Why?
Airway Obstruction
1
2015
162
0.100
 Why?
Quality Improvement
1
2022
1163
0.100
 Why?
Environmental Exposure
3
2006
572
0.100
 Why?
Forecasting
1
2015
388
0.100
 Why?
Transplantation
1
2013
34
0.100
 Why?
Bronchial Hyperreactivity
3
2010
111
0.100
 Why?
Office Visits
4
2011
91
0.100
 Why?
Insurance Claim Review
1
2013
62
0.100
 Why?
Medicare
2
2022
758
0.100
 Why?
Peer Group
2
2012
241
0.100
 Why?
Double-Blind Method
5
2010
1982
0.100
 Why?
Growth
1
2012
60
0.100
 Why?
Costs and Cost Analysis
1
2013
206
0.100
 Why?
Research
1
2015
448
0.100
 Why?
Methacholine Chloride
3
2008
52
0.100
 Why?
Cytomegalovirus Infections
2
2012
192
0.100
 Why?
Antibodies, Monoclonal, Humanized
2
2008
801
0.100
 Why?
Cost of Illness
3
2003
302
0.100
 Why?
Metered Dose Inhalers
1
2012
16
0.090
 Why?
Feedback
1
2012
172
0.090
 Why?
Drug Dosage Calculations
1
2011
23
0.090
 Why?
Mycoses
1
2012
79
0.090
 Why?
Logistic Models
5
2017
2067
0.090
 Why?
Antifungal Agents
1
2012
136
0.090
 Why?
Body Height
1
2012
199
0.090
 Why?
Effect Modifier, Epidemiologic
1
2011
12
0.090
 Why?
Multivariate Analysis
7
2017
1507
0.090
 Why?
Professional Role
1
2012
165
0.090
 Why?
Morbidity
2
2022
323
0.090
 Why?
Medication Errors
1
2012
95
0.090
 Why?
Mycobacterium
1
2012
108
0.090
 Why?
Epidemiologic Studies
1
2011
72
0.090
 Why?
Obesity
3
2015
2982
0.090
 Why?
Diagnostic Errors
1
2012
170
0.090
 Why?
Patient Readmission
1
2016
694
0.090
 Why?
Secondary Prevention
1
2012
233
0.090
 Why?
Pneumococcal Vaccines
1
2012
142
0.090
 Why?
Program Development
1
2012
364
0.080
 Why?
Drug Resistance
1
2011
169
0.080
 Why?
Lung Diseases
1
2017
768
0.080
 Why?
Probability
1
2011
304
0.080
 Why?
Vitamin D Deficiency
1
2012
186
0.080
 Why?
Chi-Square Distribution
2
2017
530
0.080
 Why?
Bronchial Provocation Tests
2
2008
51
0.080
 Why?
Decision Support Techniques
2
2012
418
0.080
 Why?
Fluticasone
2
2008
90
0.080
 Why?
Ambulatory Care
2
2011
539
0.080
 Why?
Incidence
5
2020
2797
0.080
 Why?
Receptors, Corticotropin-Releasing Hormone
1
2009
29
0.080
 Why?
Algorithms
1
2017
1690
0.080
 Why?
Vital Capacity
4
2017
311
0.080
 Why?
Immunoglobulin E
2
2008
342
0.080
 Why?
Lectins, C-Type
1
2009
67
0.080
 Why?
Proportional Hazards Models
1
2012
1262
0.080
 Why?
Health Services
2
2007
104
0.080
 Why?
Health Knowledge, Attitudes, Practice
2
2012
1322
0.080
 Why?
Cross-Sectional Studies
6
2010
5424
0.080
 Why?
Medication Therapy Management
1
2010
75
0.080
 Why?
Surgical Wound Infection
1
2012
305
0.080
 Why?
Odds Ratio
4
2017
1066
0.080
 Why?
Kaplan-Meier Estimate
3
2016
888
0.080
 Why?
Pandemics
3
2022
1616
0.080
 Why?
Acute Disease
1
2011
1007
0.080
 Why?
Vitamin K Epoxide Reductases
1
2008
12
0.070
 Why?
Cytochrome P-450 CYP2C9
1
2008
20
0.070
 Why?
Eosinophil Cationic Protein
1
2008
10
0.070
 Why?
Smoking
3
2017
1620
0.070
 Why?
Mixed Function Oxygenases
1
2008
40
0.070
 Why?
Program Evaluation
1
2012
889
0.070
 Why?
Aryl Hydrocarbon Hydroxylases
1
2008
48
0.070
 Why?
Genetic Techniques
1
2008
64
0.070
 Why?
Trastuzumab
1
2008
95
0.070
 Why?
Quality-Adjusted Life Years
2
2006
113
0.070
 Why?
Insurance, Pharmaceutical Services
1
2008
22
0.070
 Why?
Markov Chains
2
2006
123
0.070
 Why?
Cost Sharing
1
2008
14
0.070
 Why?
State Health Plans
1
2008
30
0.070
 Why?
Adrenergic beta-Agonists
1
2008
133
0.070
 Why?
Smoking Cessation
1
2012
436
0.070
 Why?
Interviews as Topic
1
2011
772
0.070
 Why?
Reimbursement Mechanisms
1
2008
84
0.070
 Why?
Antibodies, Anti-Idiotypic
1
2007
59
0.070
 Why?
Chronic Disease
3
2017
1786
0.070
 Why?
Exercise Tolerance
2
2022
279
0.070
 Why?
Omalizumab
1
2007
51
0.070
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
360
0.070
 Why?
Warfarin
1
2008
153
0.070
 Why?
Factor Analysis, Statistical
1
2008
283
0.070
 Why?
Health Services Accessibility
2
2021
978
0.070
 Why?
Health Surveys
2
2006
513
0.070
 Why?
Influenza Vaccines
1
2012
537
0.070
 Why?
Databases, Factual
1
2012
1351
0.070
 Why?
Antiviral Agents
1
2012
739
0.070
 Why?
Tomography, X-Ray Computed
1
2017
2668
0.070
 Why?
Animals, Domestic
1
2006
17
0.060
 Why?
Lung Diseases, Interstitial
1
2013
636
0.060
 Why?
Animals
2
2025
36850
0.060
 Why?
Receptor, ErbB-2
1
2008
340
0.060
 Why?
Physicians, Family
2
2004
201
0.060
 Why?
Eosinophils
1
2008
332
0.060
 Why?
Biomedical Research
1
2012
688
0.060
 Why?
Health Benefit Plans, Employee
1
2005
25
0.060
 Why?
Database Management Systems
1
2005
51
0.060
 Why?
Models, Biological
1
2012
1773
0.060
 Why?
Hip Fractures
1
2006
86
0.060
 Why?
Health Policy
1
2008
385
0.060
 Why?
Patients
1
2006
174
0.060
 Why?
Insurance Coverage
1
2006
229
0.060
 Why?
Infant
3
2008
9395
0.060
 Why?
Utilization Review
1
2004
36
0.060
 Why?
Patient Education as Topic
3
2005
761
0.060
 Why?
Clinical Competence
1
2012
1094
0.050
 Why?
Body Mass Index
3
2015
2375
0.050
 Why?
Prenatal Exposure Delayed Effects
1
2010
605
0.050
 Why?
Gene Expression Profiling
1
2011
1772
0.050
 Why?
Medicaid
1
2008
433
0.050
 Why?
Mass Screening
1
2012
1267
0.050
 Why?
Anticoagulants
1
2008
664
0.050
 Why?
Vaccination
1
2012
1377
0.050
 Why?
Sex Factors
3
2016
2064
0.050
 Why?
Attitude to Health
1
2006
437
0.050
 Why?
Nitric Oxide
1
2008
915
0.050
 Why?
Anti-Bacterial Agents
2
2004
1798
0.050
 Why?
Case Management
1
2003
66
0.050
 Why?
Clinical Trials as Topic
2
2005
1044
0.050
 Why?
Parents
3
2006
1340
0.050
 Why?
Puerto Rico
1
2022
53
0.050
 Why?
Choice Behavior
1
2004
170
0.050
 Why?
Circadian Rhythm
1
2006
469
0.050
 Why?
Symptom Flare Up
1
2022
40
0.050
 Why?
Sputum
1
2004
311
0.050
 Why?
Academies and Institutes
1
2022
53
0.050
 Why?
Lung Neoplasms
1
2015
2489
0.050
 Why?
Health Services Research
1
2004
400
0.040
 Why?
Minority Groups
1
2003
266
0.040
 Why?
Survival Rate
2
2016
1964
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
75
0.040
 Why?
Electronics
1
2021
75
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2020
105
0.040
 Why?
Sample Size
1
2020
125
0.040
 Why?
Efficiency
1
2021
98
0.040
 Why?
Health Care Reform
1
2021
106
0.040
 Why?
Pragmatic Clinical Trials as Topic
1
2020
64
0.040
 Why?
Schools, Medical
1
2021
145
0.040
 Why?
Risk Assessment
3
2020
3434
0.040
 Why?
Patient Selection
2
2020
691
0.040
 Why?
Patient Compliance
2
2016
577
0.040
 Why?
Language
1
2022
292
0.040
 Why?
Stress, Psychological
1
2007
1097
0.040
 Why?
Time
1
2019
82
0.040
 Why?
Cluster Analysis
2
2014
497
0.040
 Why?
Health Education
1
2002
338
0.040
 Why?
Quality of Health Care
1
2003
634
0.040
 Why?
Republic of Korea
1
2017
36
0.040
 Why?
Poland
1
2017
35
0.040
 Why?
Bronchitis, Chronic
1
2017
25
0.040
 Why?
Cooperative Behavior
1
2021
445
0.040
 Why?
Patient-Centered Care
1
2003
522
0.030
 Why?
Sensitivity and Specificity
3
2013
1936
0.030
 Why?
Nitrogen Dioxide
1
1997
46
0.030
 Why?
Geography
1
2018
198
0.030
 Why?
Aftercare
1
2019
207
0.030
 Why?
Long-Term Care
1
2018
106
0.030
 Why?
Monitoring, Physiologic
2
2012
267
0.030
 Why?
Self Concept
1
2019
249
0.030
 Why?
Pediatrics
1
2005
1094
0.030
 Why?
Netherlands
1
2016
88
0.030
 Why?
Antineoplastic Agents
1
2008
2123
0.030
 Why?
Tuberculosis, Pulmonary
1
2017
141
0.030
 Why?
Perception
1
2019
360
0.030
 Why?
Formoterol Fumarate
1
2015
7
0.030
 Why?
Forced Expiratory Flow Rates
1
2015
14
0.030
 Why?
Ethanolamines
1
2015
17
0.030
 Why?
Salmeterol Xinafoate
1
2015
41
0.030
 Why?
Feasibility Studies
1
2020
951
0.030
 Why?
Receptors, Adrenergic, beta-2
1
2015
45
0.030
 Why?
Treatment Failure
1
2016
354
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
2052
0.030
 Why?
Postoperative Period
1
2016
343
0.030
 Why?
Self Efficacy
1
2019
393
0.030
 Why?
Education
1
2015
107
0.030
 Why?
Polymorphism, Single Nucleotide
2
2016
2184
0.030
 Why?
Age Factors
3
2008
3286
0.030
 Why?
Fatal Outcome
1
2015
303
0.030
 Why?
Immunosuppressive Agents
2
2015
889
0.030
 Why?
Pilot Projects
1
2020
1693
0.030
 Why?
Patient Acceptance of Health Care
1
2021
805
0.030
 Why?
Biopsy
2
2013
1124
0.030
 Why?
Combined Modality Therapy
1
2017
1231
0.030
 Why?
Gene Expression
1
2018
1500
0.030
 Why?
Telephone
2
2005
170
0.030
 Why?
Echinocandins
1
2012
7
0.020
 Why?
Lipopeptides
1
2012
13
0.020
 Why?
Amphotericin B
1
2012
31
0.020
 Why?
Aspergillosis
1
2012
22
0.020
 Why?
Intention to Treat Analysis
1
2012
73
0.020
 Why?
Tissue Donors
1
2015
417
0.020
 Why?
Candidiasis
1
2012
56
0.020
 Why?
Extracorporeal Membrane Oxygenation
1
2015
291
0.020
 Why?
Transplantation, Homologous
1
2013
415
0.020
 Why?
Hypoxia
1
2019
1112
0.020
 Why?
Mycobacterium avium Complex
1
2012
88
0.020
 Why?
Age Distribution
2
2003
390
0.020
 Why?
Cromolyn Sodium
2
2001
11
0.020
 Why?
Triazoles
1
2012
147
0.020
 Why?
Leukotriene Antagonists
1
2011
43
0.020
 Why?
Self Care
2
2005
375
0.020
 Why?
Functional Residual Capacity
1
2010
8
0.020
 Why?
Reference Values
1
2012
816
0.020
 Why?
Colorado
1
2021
4515
0.020
 Why?
Costa Rica
1
2010
19
0.020
 Why?
Principal Component Analysis
1
2011
194
0.020
 Why?
Nontuberculous Mycobacteria
1
2012
205
0.020
 Why?
Health
1
2010
84
0.020
 Why?
Inhalation
1
2010
29
0.020
 Why?
Genome-Wide Association Study
1
2016
1428
0.020
 Why?
Environment
1
2011
357
0.020
 Why?
Observation
1
2008
50
0.020
 Why?
Sex Ratio
1
2008
14
0.020
 Why?
Least-Squares Analysis
1
2008
79
0.020
 Why?
Models, Econometric
1
2008
34
0.020
 Why?
Prospective Studies
2
2012
7573
0.020
 Why?
Health Services Administration
1
2007
8
0.020
 Why?
Treatment Refusal
1
2008
89
0.020
 Why?
Social Isolation
1
2007
61
0.020
 Why?
Intelligence
1
2007
123
0.020
 Why?
Puberty
1
2008
146
0.020
 Why?
Body Weight
1
2011
985
0.020
 Why?
Child Behavior Disorders
1
2007
144
0.020
 Why?
Exercise
1
2016
2044
0.010
 Why?
Insurance, Health
1
2007
280
0.010
 Why?
CD4-Positive T-Lymphocytes
1
2011
1095
0.010
 Why?
Bronchoconstrictor Agents
1
2003
16
0.010
 Why?
Genotype
1
2009
1914
0.010
 Why?
Health Status Indicators
1
2004
168
0.010
 Why?
Organizational Innovation
1
2004
138
0.010
 Why?
Case-Control Studies
1
2010
3540
0.010
 Why?
Systems Integration
1
2003
37
0.010
 Why?
Computer Systems
1
2003
45
0.010
 Why?
Child Welfare
1
2004
212
0.010
 Why?
Motor Activity
1
2007
717
0.010
 Why?
Self Disclosure
1
2002
63
0.010
 Why?
Histamine H1 Antagonists
1
2002
30
0.010
 Why?
Drug Administration Schedule
1
2004
785
0.010
 Why?
Administration, Intranasal
1
2002
89
0.010
 Why?
Confidence Intervals
1
2002
328
0.010
 Why?
Regression Analysis
1
2003
1022
0.010
 Why?
Nurse's Role
1
2003
152
0.010
 Why?
Point-of-Care Systems
1
2003
163
0.010
 Why?
Health Care Surveys
1
2002
562
0.010
 Why?
Sex Distribution
1
2001
374
0.010
 Why?
Patient Satisfaction
1
2004
656
0.010
 Why?
Decision Support Systems, Clinical
1
2003
223
0.010
 Why?
Caregivers
1
2007
870
0.010
 Why?
Linear Models
1
2002
846
0.010
 Why?
Disease Management
1
2003
624
0.010
 Why?
Bronchoscopy
1
2000
223
0.010
 Why?
Internet
1
2003
647
0.010
 Why?
Pregnancy
1
2010
6729
0.010
 Why?
Survival Analysis
1
2000
1321
0.010
 Why?
Infant, Newborn
1
2004
6032
0.010
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (429) concept(s)
_
Co-Authors Expand Description
See all (19) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)